SEARCH

Current Edition

drug application

Intercept, awaiting needed trial data, pulls its NASH drug application in Europe

Intercept’s decision to withdraw an application for obeticholic acid in Europe doesn’t necessarily come as a surprise. Top executives hinted such an outcome was possible …

Continue Reading →